Back to search

University of Birmingham

Chemokine receptors as therapeutic targets in liver disease

Abstract

dc:description.abstract

There is an urgent need for new insights into the pathology of liver disease to underpin new therapeutic approaches. Chemokines and their receptors are central to the development of liver inflammation. I investigated liver disease using ex-vivo human tissue to analyse gene and protein expression in liver and the nature of inflammation. Animal models of liver disease were used to investigate the effects of manipulating the chemokine system. In Non-Alcoholic Fatty Liver Disease (NAFLD) expression of CCL2 is increased. A subset of monocytes expressed CD11c and CD206, and maintained CCR2 expression in NAFLD. The frequency of this subset was associated with insulin resistance. In animal models of NAFLD, antagonism of CCR2 improved liver disease. In mouse models of acute liver failure (ALF), expression of CCL25 was an early response after injury, a phenomenon also seen in human ALF. Influx of CCR9+ monocytes was a corresponding early event in murine liver. Prophylactic administration of a CCR9 antagonist reduced liver injury and macrophage infiltration. CXCR6 has contrasting effects in murine liver injury: damaging in acute injury but protective in chronic injury. In human liver CXCR6 promotes infiltration Natural Killer cells, particularly in primary biliary cirrhosis, but may also promote regeneration of hepatocytes.

Degree

thesis:*
Name dc:type.qualificationname
d_ph
Level dc:type.qualificationlevel
d_ph
Grantor dc:publisher.institution
University of Birmingham
Year dc:date.issued
2015

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Parker, Richard

Subjects

dc:subject × 1

Rights

Language dc:language.dcterms_iso639_2
eng

Chain of custody

source
Harvested from
University of Birmingham
Base URL
etheses.bham.ac.uk/cgi/oai2
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Parker, Richard. Chemokine receptors as therapeutic targets in liver disease. d_ph thesis, University of Birmingham, 2015.